This inventor holds 1 USPTO granted patent. Top assignees: Scripps Research Institute, University of California. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015
Title: Meghana Malur: Innovator in Influenza Treatment
Introduction
Meghana Malur is a prominent inventor based in Austin, TX, known for her significant contributions to the field of medical science. She has developed innovative methods for the protection and treatment against influenza infections. Her work focuses on modulating essential host signaling pathways to combat viral infections effectively.
Latest Patents
Meghana Malur holds a patent for a method and composition aimed at protection and treatment against influenza viral infection. This patent, which is her sole patent, involves modulating the activity of essential host signaling pathways, including the Hedgehog (Hh), Bone Morphogenetic Protein (BMP), and Notch (N) signaling pathways. The invention utilizes compounds that can alter these pathways to prevent or control symptoms associated with influenza viral infection. Additionally, the method can be used in conjunction with other therapeutic agents for enhanced treatment efficacy.
Career Highlights
Throughout her career, Meghana has worked with esteemed institutions such as the University of California and the Scripps Research Institute. Her research has been pivotal in advancing the understanding of viral infections and developing effective treatment strategies.
Collaborations
Meghana has collaborated with notable scientists, including Michael Oldstone and Margery Smelkinson. These partnerships have contributed to her innovative research and the successful development of her patent.
Conclusion
Meghana Malur's work in the field of influenza treatment showcases her dedication to medical innovation. Her patent reflects her commitment to improving health outcomes through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile